apl. Prof. Dr. Sabine Semrau


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




Exploring the Capabilities and Limitations of Large Language Models for Radiation Oncology Decision Support (2024) Putz F, Haderlein M, Lettmaier S, Semrau S, Fietkau R, Huang Y Journal article, Editorial The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy – Results of a multi-center observational study (2023) Singer S, Semrau S, Golcher H, Fechner K, Kallies A, Zapata Bonilla S, Grützmann R, et al. Journal article Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design (2023) Weissmann T, Mansoorian S, May M, Lettmaier S, Höfler D, Deloch L, Speer S, et al. Journal article Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for AI-assisted medical education and decision making in radiation oncology (2023) Huang Y, Gomaa A, Semrau S, Haderlein M, Lettmaier S, Weissmann T, Grigo J, et al. Journal article, Original article Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracy (2023) Weissmann T, Huang Y, Fischer S, Roesch J, Mansoorian S, Gaona HA, Gostian AO, et al. Journal article, Original article Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial (2023) Scheer I, Becker I, Schmitter C, Semrau S, Fietkau R, Gaipl U, Frey B, Donaubauer AJ Journal article Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control (2023) Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, et al. Journal article Positive factors on survival of head and neck cancer of unknown primary: what the clinician can do (2023) Khalil F, Koch M, Iro H, Sievert M, Haderlein M, Semrau S, Fietkau R, et al. Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, Von Der Grun J, Illmer T, Klautke G, Laban S, et al. Conference contribution Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2022) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Mueller SK, Traxdorf M, et al. Conference contribution